Evidence map›Paper›PMID 40195292›Full record

ArticleDiagnostic and interventional radiology (Ankara, Turkey)2025

Utilization of a steerable microcatheter and adjunctive techniques for prostatic artery embolization in anatomically challenging vesicoprostatic trunks.

Hippocrates Moschouris, Çağın Şentürk, Konstantinos Stamatiou

Abstract read
In one paragraph

Article in Diagnostic and interventional radiology (Ankara, Turkey), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hippocrates MoschourisTzanio General Hospital, Clinic of Radiology, Piraeus, Greece.ORCID 0000-0002-8940-8218
Çağın Şentürkİzmir Tınaztepe University Galen Hospital, Department of Interventional and Neuroendovascular Radiology, İzmir, Türkiye.ORCID 0000-0002-7581-1145
Konstantinos StamatiouTzanio General Hospital, Clinic of Urology, Piraeus, Greece.ORCID 0000-0001-7574-3069

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostatic artery (PA) origination from a common trunk with the superior vesical artery (SVA) is a frequent cause of technical difficulties in PA catheterization for PA embolization (PAE). These difficulties, which substantially increase the operative time, radiation dose, cost, and technical failure rate of PAE, can often be overcome by the utilization of a steerable microcatheter (MC) with a tip that can be manually adjusted at an angle that optimally conforms to the shape and origin of the common vesicoprostatic trunk. Adjunctive techniques that can be applied when the steerable MC fails to engage the PA include: 1) the protective temporary embolization of the SVA so that a permanent embolic can be redirected into the PA; 2) PAE via collaterals between superior vesical branches and the PA; and 3) embolization from a proximal position of the MC near the PA orifice to exploit preferential flow to the PA. In the authors' recent experience, the utilization of a steerable MC with and without adjunctive techniques (in 12 and 23 patients, respectively) resulted in a 35% increase in the technically successful embolization of PAs originating from vesicoprostatic trunks with no significant complications. Familiarization with alternative devices and techniques may substantially improve the technical outcome of PAE in cases with challenging arterial anatomy.

Indexed as

ArteriesEmbolization, TherapeuticProstateProstatic HyperplasiaAgedAged, 80 and overCathetersHumansMaleMiddle AgedTreatment OutcomeAngiographymicrocatheterprostatic arteryprostatic artery embolizationvesicoprostatic trunk

Identifiers

PMID40195292
PMCPMC12417901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.